| Balance Sheets | 2025-09-30 | |||
|---|---|---|---|---|
| Cash | 2,656,519 | |||
| Prepaid expenses and other current assets, net | 3,187,614 | |||
| Total current assets | 5,844,133 | |||
| Equipment, gross | 1,851,924 | |||
| Less accumulated depreciation | 1,570,654 | |||
| Equipment, net | 281,270 | |||
| Right-of-use assets, net | 42,797 | |||
| Other non-current assets | 74,770 | |||
| Total non-current assets | 398,837 | |||
| Total assets | 6,242,970 | |||
| Accounts payable, accruals, and other current liabilities (including amount due to related parties major stockholders as of september 30, 2025 and june 30, 2025, with 50,013 and 172,767, and due to related parties related corporations with 1,435,065 and 916,036, respectively ) | 3,017,018 | |||
| Lease payable - current | 27,934 | |||
| Total current liabilities | 3,044,952 | |||
| Amount due to related parties non-current-Corporate Joint Venture | 190,959 | |||
| Lease payable non-current | 2,935 | |||
| Total non-current liabilities | 193,894 | |||
| Total liabilities | 3,238,846 | |||
| Common stock 0.001 par value per share as of september 30, 2025 and june 30, 2025 400,000,000 and 400,000,000 shares authorized 21,640,000 and 21,640,000 shares issued and outstanding, respectively | 21,640 | |||
| Additional paid-in capital | 21,347,278 | |||
| Accumulated deficits | -19,619,945 | |||
| Accumulated other comprehensive income | 1,255,151 | |||
| Total stockholders equity | 3,004,124 | |||
| Total liabilities and stockholders equity | 6,242,970 | |||
Advanced Biomed Inc. (ADVB)
Advanced Biomed Inc. (ADVB)